Matrix metalloproteinase inhibition suppresses MMP-2 activity and activation of PANC-1 cells in vitro

Journal of Surgical Research

Volumn 84, Issue 2, 1999, Pages 162-167

  Zervos, Emmanuel E ^a   Shafii, Alexis E ^a   Haq, Mahmudul ^a   Rosemurgy, Alexander S ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

BB 94; Matrigel; Metalloproteinase; Pancreatic cancer

Indexed keywords

BATIMASTAT; GELATINASE A; MATRIX METALLOPROTEINASE INHIBITOR;

ANIMAL CELL; ARTICLE; CANCER SURVIVAL; DRUG EFFECT; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; PANCREAS CANCER; PRIORITY JOURNAL;

EID: 0033563795     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1999.5632     Document Type: Article

References (22)

1. Matrisian L. M. The matrix-degrading metalloproteinases. Bioessays. 14:1992;455.
2. Agren M. S., Taplin C. J., Woessner J. F., Eaglestein W. H., Mertz P. M. Collagenase activity during wound healing. J. Invest. Dermatol. 98:1992;621.
3. Reponen P., Sahlberg C., Huhtala P., Jurskainen T., Thesleff I., Tryggvason K. Molecular cloning of murine 72 kD type IV collagenase and its expression during mouse development. J. Biol. Chem. 267:1992;7856.
4. Tryggvason K., Hoyhtya M., Pyke C. Type IV collagenases in invasive tumors [Review]. Breast Cancer Res. Treat. 24:1993;209.
5. Waxman J. The architecture of cancer. The tissue metalloproteinases and their inhibitors. Br. Med. J. 305:1992;1306.
6. Van der Stappen J. W., Hendriks T., Wobbes T. Correlation between collagenolytic activity and grade of histologic differentiation in colorectal tumors. Int. J. Cancer. 45:1990;1071.
7. Davies B., Miles D. W., Happerfield M. L. C., Naylor M. S., Bobrow L. G., Rubens R. D., Balkwill F. R. Activity of type IV collagenases in benign and malignant breast disease. Br. J. Cancer. 67:1993;1126.
8. Levy J. T., Cioce V., Sobel M. E., Garbisa S., Grigioni W. F., Liotta L. A., Stetler-Stevenson W. G. Increased expression of the Mr 72,000 type IV collagenase in human colonic adenocarcinoma. Cancer Res. 51:1991;439.
9. Koshiba T., Wada M., Fujimot K., Lee J. U., Kato M., Doi R., Shimada Y., Hosotani R., Arii S., Imamura M. Activation of MMP-2 and MMP-9 in human pancreatic cancer tissues and human pancreatic cancer cell lines. Gastroenterology. 110:1996;A545.
10. Liabakk N. B., Talbot I., Smith R. A., Wilkinson K., Balkwill F. Matrix metalloprotease 2 (MMP-2) and matrix metalloprotease 9 (MMP-9) type IV collagenases in colorectal cancer. Cancer Res. 56:1996;190.
11. Zervos, E, Shafii, A, and, Rosemurgy, A. Matrix metalloproteinase inhibition selectively decreases type II MMP activity in a murine model of pancreatic cancer, J. Surg. Res, in press.
12. Koshiba T., Hosotani R., Wada M., Fujimoto K., Lee J., Doi R., Arii S., Imamur M. Detection of matrix metalloproteinase activity in human pancreatic cancer. Surg. Today. 27:1997;302.
13. Bramhall S., Stamp G., Dunn J., Lemoine N. R., Neoptolemos J. Expression of collagenases (MMP-2), stromelysin (MMP-3) and tissue inhibitor of metalloproteinases (TIMP-1) in pancreatic and ampullary disease. Br. J. Cancer. 73:1996;972.
14. Gress T., Muller-Pillasch F., Lerch M., Buchler M., Adler G. Expression and in-situ localization of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in pancreatic cancer. Int. J. Cancer. 62:1995;407.
15. Evans J., Ghaneh P., Kawesha A., Neoptolemos J. Role of matrix metalloproteinases and their inhibitors in pancreatic cancer. Digestion. 58:1997;520.
16. Zervos E. E., Norman J. G., Gower W. R., Franz M. G., Rosemurgy A. S. Matrix metalloproteinase inhibition attenuates human pancreatic cancer growth in vitro and decreases mortality and tumorigenesis in vivo. J. Surg. Res. 69:1997;367.
17. DeClerck Y. A., Imren S. Protease inhibitors: role and potential therapeutic use in human cancer. Eur. J. Cancer. 14:1994;2170.
18. Imai K., Eiko O., Takanori A., Hidehiro N., Yutaka F., Hiroshi S., Motoharu S., Ysunori O. Membrane type matrix metalloproteinase 1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinase 2. Cancer Res. 56:1996;2707.
19. Strongin A., Collier I., Bannikov G., Marmer B. L., Grandt G., Goldberg G. Mechanism of cell surface activation of 72-kDa type IV collagenase. J. Biol. Chem. 270:1995;5331.
20. Sato H., Takino T., Okada Y., Cao J., Shingawa A., Yamamoto E., Seiki M. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature. 370:1994;61.
21. Yamamoto M., Mohanam S., Sawaya R., Fuller G., Seiki M., Sato H., Gokaslan Z., Liotta L., Nicolson G., Rao J. Differential expression of membrane type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro. Cancer Res. 56:1996;384.
22. Brown P. D., Bloxidge R. E., Stewart N. S., Gatter K. C., Carmichael J. Association between expression of activated 72 kD gelatinase and tumor spread in non-small cell lung carcinoma. J. Natl. Cancer Inst. 85:1993;574.